"RIV/00216208:11160/10:00300522" . . "Vit\u00E1sek, Zden\u011Bk" . "V\u00FDznam sledov\u00E1n\u00ED spot\u0159eby l\u00E9\u010Div ve farmakoepidemiologii na p\u0159\u00EDkladech longotudin\u00E1ln\u00EDch studi\u00ED inhibitor\u016F protonov\u00E9 pumpy, antibiotik a metforminu"@cs . "Tlust\u00E1, Eva" . . "Importance of drug utilization studies in pharmacoepidemiology on examples of longitudinal studies of proton pump inhibitors, antibiotics and metformin"@en . . . "1212-7973" . "V\u00FDznam sledov\u00E1n\u00ED spot\u0159eby l\u00E9\u010Div ve farmakoepidemiologii na p\u0159\u00EDkladech longotudin\u00E1ln\u00EDch studi\u00ED inhibitor\u016F protonov\u00E9 pumpy, antibiotik a metforminu"@cs . "Ku\u010Derov\u00E1-Lamkov\u00E1, Andrea" . "Database of the SUKL and health insurance company was used in our study to analyse consumption of proton pump inhibitors (PPI), antibiotics and metformin. The rapid increase in utilization of PPI was demonstrated with omeprazol the most frequently used. Consumption of metformin increased more than twice in the period from 2001 to 2008. Penicillines were the most frequently prescribed antibiotics, mainly amoxicillin in combination with clavulanic acid."@en . "[5ECD6A65D91F]" . "298353" . "24" . "5"^^ . "Buri\u00E1nkov\u00E1, Lenka" . "V\u00FDznam sledov\u00E1n\u00ED spot\u0159eby l\u00E9\u010Div ve farmakoepidemiologii na p\u0159\u00EDkladech longotudin\u00E1ln\u00EDch studi\u00ED inhibitor\u016F protonov\u00E9 pumpy, antibiotik a metforminu" . . . . . . "Klinick\u00E1 farmakologie a farmacie" . . . "V\u00FDznam sledov\u00E1n\u00ED spot\u0159eby l\u00E9\u010Div ve farmakoepidemiologii na p\u0159\u00EDkladech longotudin\u00E1ln\u00EDch studi\u00ED inhibitor\u016F protonov\u00E9 pumpy, antibiotik a metforminu" . "Vl\u010Dek, Ji\u0159\u00ED" . "drug utilization; ATC/DDD methodology; proton pump inhibitors; antibiotics; metformin"@en . . "CZ - \u010Cesk\u00E1 republika" . "S" . . "RIV/00216208:11160/10:00300522!RIV11-MSM-11160___" . "4"^^ . . . "11160" . "Importance of drug utilization studies in pharmacoepidemiology on examples of longitudinal studies of proton pump inhibitors, antibiotics and metformin"@en . "Ve studii byla pou\u017Eita datab\u00E1ze S\u00DAKL a datab\u00E1ze zdravotn\u00ED poji\u0161\u0165ovny pro sledov\u00E1n\u00ED spot\u0159eby inhibitor\u016F protonov\u00E9 pumpy (PPI), antibiotik a metforminu. V\u00FDsledky dokl\u00E1daj\u00ED strm\u00FD n\u00E1r\u016Fst spot\u0159eby PPI (neju\u017E\u00EDvan\u011Bj\u0161\u00ED omeprazol), spot\u0159eba metforminu se od roku 2001 do roku 2008 v\u00EDce ne\u017E zdvojn\u00E1sobila. Z antibiotik jsou nejv\u00EDce u\u017E\u00EDv\u00E1ny peniciliny, zejm\u00E9na potencovan\u00FD amoxicilin." . . "Ve studii byla pou\u017Eita datab\u00E1ze S\u00DAKL a datab\u00E1ze zdravotn\u00ED poji\u0161\u0165ovny pro sledov\u00E1n\u00ED spot\u0159eby inhibitor\u016F protonov\u00E9 pumpy (PPI), antibiotik a metforminu. V\u00FDsledky dokl\u00E1daj\u00ED strm\u00FD n\u00E1r\u016Fst spot\u0159eby PPI (neju\u017E\u00EDvan\u011Bj\u0161\u00ED omeprazol), spot\u0159eba metforminu se od roku 2001 do roku 2008 v\u00EDce ne\u017E zdvojn\u00E1sobila. Z antibiotik jsou nejv\u00EDce u\u017E\u00EDv\u00E1ny peniciliny, zejm\u00E9na potencovan\u00FD amoxicilin."@cs . . "2" . . . "5"^^ .